BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 30554402)

  • 1. The Challenge to Search for New Nervous System Disease Biomarker Candidates: the Opportunity to Use the Proteogenomics Approach.
    Nery TGM; Silva EM; Tavares R; Passetti F
    J Mol Neurosci; 2019 Jan; 67(1):150-164. PubMed ID: 30554402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteogenomics: Key Driver for Clinical Discovery and Personalized Medicine.
    Barbieri R; Guryev V; Brandsma CA; Suits F; Bischoff R; Horvatovich P
    Adv Exp Med Biol; 2016; 926():21-47. PubMed ID: 27686804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteogenomics: From next-generation sequencing (NGS) and mass spectrometry-based proteomics to precision medicine.
    Ang MY; Low TY; Lee PY; Wan Mohamad Nazarie WF; Guryev V; Jamal R
    Clin Chim Acta; 2019 Nov; 498():38-46. PubMed ID: 31421119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutant Proteogenomics.
    Végvári Á
    Adv Exp Med Biol; 2016; 926():77-91. PubMed ID: 27686807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JUMPg: An Integrative Proteogenomics Pipeline Identifying Unannotated Proteins in Human Brain and Cancer Cells.
    Li Y; Wang X; Cho JH; Shaw TI; Wu Z; Bai B; Wang H; Zhou S; Beach TG; Wu G; Zhang J; Peng J
    J Proteome Res; 2016 Jul; 15(7):2309-20. PubMed ID: 27225868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteogenomics Reveals Orthologous Alternatively Spliced Proteoforms in the Same Human and Mouse Brain Regions with Differential Abundance in an Alzheimer's Disease Mouse Model.
    da Silva EMG; Santos LGC; de Oliveira FS; Freitas FCP; Parreira VDSC; Dos Santos HG; Tavares R; Carvalho PC; Neves-Ferreira AGDC; Haibara AS; de Araujo-Souza PS; Dias AAM; Passetti F
    Cells; 2021 Jun; 10(7):. PubMed ID: 34201730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteogenomics from a bioinformatics angle: A growing field.
    Menschaert G; Fenyö D
    Mass Spectrom Rev; 2017 Sep; 36(5):584-599. PubMed ID: 26670565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteogenomics for understanding oncology: recent advances and future prospects.
    Subbannayya Y; Pinto SM; Gowda H; Prasad TS
    Expert Rev Proteomics; 2016; 13(3):297-308. PubMed ID: 26697917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteoform Identification by Combining RNA-Seq and Top-Down Mass Spectrometry.
    Chen W; Liu X
    J Proteome Res; 2021 Jan; 20(1):261-269. PubMed ID: 33183009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteogenomics-Guided Evaluation of RNA-Seq Assembly and Protein Database Construction for Emergent Model Organisms.
    Cogne Y; Gouveia D; Chaumot A; Degli-Esposti D; Geffard O; Pible O; Almunia C; Armengaud J
    Proteomics; 2020 May; 20(10):e1900261. PubMed ID: 32249536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of Proteogenomics with Peptide
    Blank-Landeshammer B; Teichert I; Märker R; Nowrousian M; Kück U; Sickmann A
    mBio; 2019 Oct; 10(5):. PubMed ID: 31615963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Connecting Proteomics to Next-Generation Sequencing: Proteogenomics and Its Current Applications in Biology.
    Low TY; Mohtar MA; Ang MY; Jamal R
    Proteomics; 2019 May; 19(10):e1800235. PubMed ID: 30431238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PROTEOFORMER 2.0: Further Developments in the Ribosome Profiling-assisted Proteogenomic Hunt for New Proteoforms.
    Verbruggen S; Ndah E; Van Criekinge W; Gessulat S; Kuster B; Wilhelm M; Van Damme P; Menschaert G
    Mol Cell Proteomics; 2019 Aug; 18(8 suppl 1):S126-S140. PubMed ID: 31040227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis and translational perspective of hepatocellular carcinoma: Identification of diagnostic protein biomarkers by an onco-proteogenomics approach.
    Chiou SH; Lee KT
    Kaohsiung J Med Sci; 2016 Nov; 32(11):535-544. PubMed ID: 27847095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Proteome Profiling and Mutant Protein Identification in Metastatic Prostate Cancer Cells by Quantitative Mass Spectrometry-based Proteogenomics.
    Kwon OK; Ha YS; Lee JN; Kim S; Lee H; Chun SY; Kwon TG; Lee S
    Cancer Genomics Proteomics; 2019; 16(4):273-286. PubMed ID: 31243108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accurate Prediction of Protein Sequences for Proteogenomics Data Integration.
    Hagemeijer YP; Guryev V; Horvatovich P
    Methods Mol Biol; 2022; 2420():233-260. PubMed ID: 34905178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteogenomics approaches for studying cancer biology and their potential in the identification of acute myeloid leukemia biomarkers.
    Hernandez-Valladares M; Vaudel M; Selheim F; Berven F; Bruserud Ø
    Expert Rev Proteomics; 2017 Aug; 14(8):649-663. PubMed ID: 28693350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteogenomic Methods to Improve Genome Annotation.
    Datta KK; Madugundu AK; Gowda H
    Methods Mol Biol; 2016; 1410():77-89. PubMed ID: 26867739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flexible Data Analysis Pipeline for High-Confidence Proteogenomics.
    Weisser H; Wright JC; Mudge JM; Gutenbrunner P; Choudhary JS
    J Proteome Res; 2016 Dec; 15(12):4686-4695. PubMed ID: 27786492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A proteogenomics data-driven knowledge base of human cancer.
    Liao Y; Savage SR; Dou Y; Shi Z; Yi X; Jiang W; Lei JT; Zhang B
    Cell Syst; 2023 Sep; 14(9):777-787.e5. PubMed ID: 37619559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.